Lymphangioleiomyomatosis digital illustration

Lymphangioleiomyomatosis Save


ICD-10 code: J84.81

Disease category: J84.8: Other specified interstitial pulmonary diseases

Lymphangioleiomyomatosis: A Rare Lung Disease

Lymphangioleiomyomatosis (LAM) is a rare lung disease that primarily affects women of childbearing age. It is characterized by the abnormal growth of smooth muscle cells in the lungs, leading to the formation of cysts and the progressive destruction of lung tissue.

While the exact cause of LAM is still unknown, it is believed to be related to an abnormal growth of cells in the lymphatic system. LAM is often associated with another rare genetic disorder called tuberous sclerosis complex (TSC), which affects multiple organs including the brain, skin, kidneys, and heart. However, not all LAM cases are linked to TSC.

Common symptoms of LAM include shortness of breath, chest pain, coughing, and wheezing. As the disease progresses, it can cause lung collapse, pneumothorax, and respiratory failure. LAM is typically diagnosed through a combination of clinical evaluation, lung function tests, high-resolution computed tomography (HRCT), and biopsy if necessary.

Here are some key facts about LAM:

  1. LAM primarily affects women of childbearing age.
  2. It is a rare lung disease characterized by the abnormal growth of smooth muscle cells in the lungs.
  3. LAM can cause symptoms such as shortness of breath, chest pain, coughing, and wheezing.
  4. It is often associated with tuberous sclerosis complex (TSC), but not all LAM cases are linked to TSC.
  5. LAM diagnosis involves clinical evaluation, lung function tests, HRCT, and biopsy if necessary.

Although there is currently no cure for LAM, various treatment options are available to manage symptoms and slow down disease progression. These include the use of bronchodilators to improve airflow, oxygen therapy, and the prescription of medications such as sirolimus to inhibit cell growth. Additionally, lung transplantation may be considered for individuals with advanced LAM and severe lung damage.

In conclusion, Lymphangioleiomyomatosis is a rare lung disease primarily affecting women of childbearing age. Understanding its symptoms, diagnosis methods, and the association with tuberous sclerosis complex is crucial for early detection and appropriate management of the disease.

Treatment of Lymphangioleiomyomatosis:

Treatment Options for Lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is a rare lung disease that primarily affects women. It is characterized by an abnormal growth of smooth muscle cells in the lungs, leading to the formation of cysts and impairing lung function. While there is no cure for LAM, several treatment options can help manage the symptoms and slow down the progre...

To see full information about treatment please Sign up or Log in